Lahariya Chandrakant
Formerly Department of Community Medicine, G.R. Medical College, Gwalior, India.
Indian J Med Res. 2014 Apr;139(4):491-511.
The challenges faced in delivering lifesaving vaccines to the targeted beneficiaries need to be addressed from the existing knowledge and learning from the past. This review documents the history of vaccines and vaccination in India with an objective to derive lessons for policy direction to expand the benefits of vaccination in the country. A brief historical perspective on smallpox disease and preventive efforts since antiquity is followed by an overview of 19 th century efforts to replace variolation by vaccination, setting up of a few vaccine institutes, cholera vaccine trial and the discovery of plague vaccine. The early twentieth century witnessed the challenges in expansion of smallpox vaccination, typhoid vaccine trial in Indian army personnel, and setting up of vaccine institutes in almost each of the then Indian States. In the post-independence period, the BCG vaccine laboratory and other national institutes were established; a number of private vaccine manufacturers came up, besides the continuation of smallpox eradication effort till the country became smallpox free in 1977. The Expanded Programme of Immunization (EPI) (1978) and then Universal Immunization Programme (UIP) (1985) were launched in India. The intervening events since UIP till India being declared non-endemic for poliomyelitis in 2012 have been described. Though the preventive efforts from diseases were practiced in India, the reluctance, opposition and a slow acceptance of vaccination have been the characteristic of vaccination history in the country. The operational challenges keep the coverage inequitable in the country. The lessons from the past events have been analysed and interpreted to guide immunization efforts.
要将拯救生命的疫苗提供给目标受益人群,就需要从现有知识以及过去的经验教训中去应对所面临的挑战。本综述记录了印度疫苗和疫苗接种的历史,目的是汲取经验教训,为扩大该国疫苗接种益处的政策方向提供指导。首先简要介绍了自古至今天花疾病及预防措施的历史概况,接着概述了19世纪用疫苗接种取代人痘接种的努力、一些疫苗机构的设立、霍乱疫苗试验以及鼠疫疫苗的发现。20世纪初见证了天花疫苗接种推广过程中面临的挑战、在印度军队人员中进行的伤寒疫苗试验,以及当时几乎每个印度邦都设立了疫苗机构。在独立后时期,建立了卡介苗疫苗实验室和其他国家机构;除了持续开展天花根除工作直至1977年该国消灭天花外,还出现了许多私营疫苗制造商。印度启动了扩大免疫规划(EPI)(1978年),随后又启动了全民免疫规划(UIP)(1985年)。文中描述了自全民免疫规划实施至2012年印度宣布脊髓灰质炎为非地方性疾病期间的相关事件。尽管印度一直在开展疾病预防工作,但民众对接种疫苗的不情愿、反对以及缓慢接受一直是该国疫苗接种历史的特点。这些操作上的挑战导致该国疫苗接种覆盖率不均衡。对过去事件的经验教训进行了分析和解读,以指导免疫工作。